Hanmi Financial buy krebskrebs
Start price
02.06.20
/
50%
€8.15
Target price
04.11.21
€8.00
Performance (%)
150.75%
End price
05.11.21
€19.90
Summary
This prediction ended on 05.11.21 with a price of €19.90. With a performance of 150.75% the BUY prediction by krebskrebs was a big success. Dividends of €0.54 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Hanmi Financial | -5.036% | -5.036% | 30.693% | 61.963% |
| iShares Core DAX® | -1,59 % | 5,03 % | 6,33 % | 64,06 % |
| iShares Nasdaq 100 | -4,15 % | -0,13 % | 25,73 % | 86,92 % |
| iShares Nikkei 225® | -6,30 % | 0,53 % | 41,38 % | 77,87 % |
| iShares S&P 500 | -3,23 % | 0,47 % | 20,45 % | 68,19 % |
Comments by krebskrebs for this prediction
In the thread Hanmi Financial diskutieren
Buy mit Kursziel 8,0
In the thread Trading Hanmi Financial
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

